Cargando…
Tripartite motif 38 alleviates the pathological process of NAFLD–NASH by promoting TAB2 degradation
Nonalcoholic fatty liver disease (NAFLD) has become the most prevalent chronic liver disease worldwide, without any Food and Drug Administration-approved pharmacological intervention in clinic. Trim38, as an important member of the TRIM (tripartite motif-containing) family, was largely reported to b...
Autores principales: | Yao, Xinxin, Dong, Ruixiang, Hu, Sha, Liu, Zhen, Cui, Jie, Hu, Fengjiao, Cheng, Xu, Wang, Xiaoming, Ma, Tengfei, Tian, Song, Zhang, Xiao-Jing, Hu, Yufeng, Bai, Lan, Li, Hongliang, Zhang, Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394331/ https://www.ncbi.nlm.nih.gov/pubmed/37116711 http://dx.doi.org/10.1016/j.jlr.2023.100382 |
Ejemplares similares
-
Tripartite motif 38 attenuates cardiac fibrosis after myocardial infarction by suppressing TAK1 activation via TAB2/3 degradation
por: Lu, Zhengri, et al.
Publicado: (2022) -
Upregulation of BCL-2 by acridone derivative through gene promoter i-motif for alleviating liver damage of NAFLD/NASH
por: Li, Xiaoya, et al.
Publicado: (2020) -
Natural History of NAFLD/NASH
por: Ekstedt, Mattias, et al.
Publicado: (2017) -
The role of the microbiome in NAFLD and NASH
por: Kolodziejczyk, Aleksandra A, et al.
Publicado: (2018) -
Noninvasive Diagnosis of NAFLD and NASH
por: Piazzolla, Valeria Annarita, et al.
Publicado: (2020)